exam 3 all material

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/591

flashcard set

Earn XP

Description and Tags

bruh

Last updated 4:00 AM on 4/15/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

592 Terms

1
New cards

what is targeted therapy?

A cancer treatment that targets proteins/genes associated with growth and metastasis of cancer

2
New cards

targeted therapy acts on _________

specific molecular targets

3
New cards

targeted therapy is ____ and chemotherapy is ____

a. cytotoxic, cytotoxic

b. cytostatic, cytotoxic

c. cytotoxic, cytostatic

d. cytostatic, cytostatic

b

4
New cards

chemotherapy acts on…

all rapidly dividing cells

5
New cards

why is companion diagnosis essential for targeted therapy? (3)

  1. can tell if a pt would benefit from a specific targeted therapy

  2. can tell if a pt would be at a higher risk for ADE from specific targeted therapies

  3. can monitor treatment and progression in pts on targeted therapy

6
New cards

name the two types of targeted therapy

small molecule inhibitors

monoclonal antibodies

7
New cards

how do small molecule inhibitors work?

they enter cells and inhibit intracellular targets

8
New cards

SMIs:

  1. admin route

  2. typical targets

  1. oral

  2. kinases

9
New cards

monoclonal antibodies targets are …

on the cell surface

10
New cards

Which targets intracellular pathways?

a. small molecule inhibitors

b. monoclonal antibodies

a

11
New cards

mabs admin route

IV

12
New cards

common ADE of all targeted therapies (3)

diarrhea, liver problems, and skin problems

13
New cards

other ADE of targeted therapies include… (6)

HTN

Fatigue

Rash

Mouth sores

Nail changes

Loss of hair color

14
New cards

Which oncogene is most commonly mutated?

RAS

15
New cards

What happens when Ras is mutated?

cancer growth due to constant activation

16
New cards

what type of receptor is EGFR?

tyrosine kinase receptors

17
New cards

when EGFR is activated, it leads to…

increased proliferation

increased metastasis

decreased apoptosis

18
New cards

cells expressing EGFR are resistant to…

cytotoxins

19
New cards

Which receptor is important in breast cancer?

HER2

20
New cards

of the HER dimers, which is the most potent and activates RAS MAPK and the STAT pathways?

HER1/HER2

21
New cards

name the antiEGFR mabs

Cetuximab

panitumumab

22
New cards

which drugs targets HER2

Trastuzumab

pertizumab

23
New cards

Trastuzumab MOA

downregulates HER2 signaling by masking protease cleavage site and blocking shedding of the receptor

ultimately leads to activation of the TK domain to

24
New cards

consequences of HER targeted therapies

drug resistance

25
New cards

name 4 tyrosine kinase inhibitors

Afatinib

Erlotinib

getitinib

osimertinib

26
New cards

Afatinib

  1. class

  2. target

  3. fatal ADE

  1. SMI / EFGR TKI

  2. TK EGFR, HER 2, and HER4

  3. interstitial lung disease, sepsis, and pneumonia

27
New cards

Erlotinib

  1. target

  2. most common ADE

  1. TK EGFR

  2. rash and diarrhea

28
New cards

name the EGFR TKIs

  1. Gefitinib

  2. erlotinib

  3. afatinib

  4. osimertinib

29
New cards

name the multikinase TKIs

Sunitinib

sorafenib

30
New cards

what does ALK code for

tyrosine kinases

31
New cards

MOA of ALK tyrosine kinase inhibitors

competitive inhibition of the ATP binding site on the ALK receptor

32
New cards

name the ALK TKIs

crizotinib

ceritinib

alectinib

lorlatinib

33
New cards

ceritinib targets (4)

tyrosine kinase, ALK, IGF1, and ROS1

34
New cards

Alectinib targets

ALK and RET

35
New cards

Lorlatinib and brigatinib targets

ALK and ROS1

36
New cards

what proteins are considered molecular switches?

RAS

37
New cards

Dabrafenib

  1. class

  2. target

  3. severe ADE

  1. SMI

  2. BRAF

  3. carcinoma, hypotension, kidney failure

38
New cards

name the MEK inhibitor

Trametinib

39
New cards

Trametinib

  1. class

  2. target

  3. ADE

  1. SMI

  2. MEK

  3. rash, diarrhea, edema

40
New cards

name the CDK inhibitor

Palbociclib

41
New cards

name the PI3K inhibitor

Idelalisib

42
New cards

name the mTOR inhibitor

Everolimus

43
New cards

what pathway promotes growth / proliferation

RAS / MAPK

44
New cards

what pathway promotes survival (anti-apoptosis)

PI3K / AKT / mTOR

45
New cards

which pathway promotes the cell cycle division

CDK

46
New cards

name the proteins that are pro-apoptosis

BAD

NOXA

BAX

BAK

47
New cards

name the proteins that are anti-apoptosis

Bcl-2

Bcl-xl

48
New cards

Which of the following does not promotes apoptosis?

a. bcl-2

b. NOXA

c. BAD

d. BAK

a

49
New cards

what is nausea

feeling like you are going to throw up / queasy feeling

50
New cards

what is vomitting?

expelling the contents of the GIT

51
New cards

what are the 4 types of N/V associated with chemo?

  1. anticipatory

  2. acute

  3. delayed

  4. breakthrough

52
New cards

define anticipatory CINV

N/V before chemotherapy likely due to anxiety from a previous bad reaction

53
New cards

define acute CINV

occurs on day 1 of chemo

54
New cards

define delayed CINV

occurs after day 1 of chemotherapy to day 5 of chemo

55
New cards

define breakthrough CINV

N/V that can occur at any time during chemotherapy

56
New cards

what are some risk factors of acute CINV

women, younger age, chemotherapy regimen

57
New cards

name the 4 medications/ classes that are indicated for acute CINV prophylaxis

5HT3 inhibitors (-setron)

NK1 antagonists (-pitant)

dexamethasone

olanzapine

58
New cards

name the 3 medications/ classes that are indicated for delayed CINV prophylaxis

NK1 antagonists (-pitants)

dexamethasone

olanzapine

59
New cards

which of the following drugs/classes is NOT indicated for delayed CINV prophylaxis?

a. olanzapine

b. dexamethasone

c. NK1 antagonists

d. 5HT3 inhibitors

d

60
New cards

NK1 antagonist medications all end with…

-pitant

61
New cards

which class of medications has long half lives so the effects last for multiple days?

NK1 antagonists

62
New cards

T or F:

NK1 antagonists are generally well tolerated

T

63
New cards

NK1 antagonists are ____ therapy only

a. mono

b. combo

b

64
New cards

when would NK1 antagonists be given for CINV prophylaxis and why?

day 1 of chemotherapy because they treat acute N/V and last for a long time

65
New cards

5HT3 antagonists all end with…

-setron

66
New cards

-setron is the suffix for which class of medications?

5HT3 inhibitors

67
New cards

which class of agents for CINV is associated with QTc prolongation?

-setrons (5HT3 inhibitors)

68
New cards

-setrons (5HT3 inhibitors) are associated with causing what severe ADE?

QTc prolongation

69
New cards

what patient demographics are at higher risk of QTc prolongation while on 5HT3 inhibitors?

CHF

congenital QTc prolonging syndrome

bradyarrhythmias

taking other meds that can prolong QTc

70
New cards

most important patient counseling for 5HT3 inhibitors

keep track of other QTc prolonging agents

71
New cards

counseling points for 5HT3 inhibitors (-setrons)

keep track of other QTc prolonging agents

maintain K and Mg levels

72
New cards

what is the maximum dose of ondansetron? and the method of delivery?

16 mg IV

73
New cards

which delivery method of 5HT3 inhibitors (-setrons) is known to cause more QTc prolongation?

IV

74
New cards

which 5HT3 inhibitors (-setron) has the lowest risk of QTc prolongation?

palonosetron

75
New cards

5HT3 inhibitors (-setron) ADEs

QTc prolongation

HA

constipation

76
New cards

high emetic risk prophylaxis:

day 1 regimen (aka acute tx)

NK1 antagonist (-pitant)

5HT3 inhibitor (-setron)

Dexamethasone

Olanzapine

77
New cards

high emetic risk prophylaxis:

days 2-4 regimen

Dexamethasone 8 mg PO or IV daily

Olanzapine 2.5-10 mg PO qhs

78
New cards

olanzapine main ADE

sedation

79
New cards

moderate emetic risk acute CINV prophylaxis:

pt on high dose carboplatin regimen

NK1 antagonist (-pitant)

5HT3 inhibitor: (-setron)

Dexamethasone 12 mg PO or IV

80
New cards

moderate emetic risk acute CINV prophylaxis:

pt on low dose carboplatin or not on carboplatin regimen

5HT3 inhibitor (-setron)

Dexamethasone 8 mg PO or IV

81
New cards

Moderate emetic risk for delayed CINV prophylaxis:

these pts only need to be treated if they are on…

agents with increased risk of N/V

82
New cards

Moderate emetic risk for delayed CINV prophylaxis:

treatment (must be on agent with increased risk)

dexamethasone

83
New cards

low emetic risk acute CINV prophylaxis:

OPTIONS

dexamethason 8 mg PO or IV

OR
5HT3 inhibitor (-setron)

84
New cards

low emetic risk delayed CINV prophylaxis:

regimen

none, tricked you 🤪

85
New cards

how to prevent anticipatory CINV?

use appropriate anti-emetic prophylaxis so they dont get anxiety about it

86
New cards

most effective method of anticipatory CINV treatment

behavioral therapy

87
New cards

anticipatory CINV:

tx options

po benzo the night before treatment and 1-2 hrs before chemotherapy

or

olanzapine 2.5-5 mg the night before chemotherapy

88
New cards

anticipatory CINV:

what benzo and dose is typically used?

lorazepam 0.5-1 mg

89
New cards

breakthrough emesis:

how to treat?

add another agent with a different MOA

if the med is working switch from prn to scheduled dosing

90
New cards

ORAL chemo CINV moderate to high risk prophylaxis:

treatment options

5HT3 inhibitor PO 30 min b4 medication

or

olanzapine 2.5-10 mg PO qhs

91
New cards

ORAL chemo CINV low to minimal risk prophylaxis:

treatment options

nothing or have a breakthrough medication ready (tbh im confused)

92
New cards

name the three kinds of bone marrow suppression that can be caused by malignancy or cancer treatment

anemia

thrombocytopenic

neutropenia

93
New cards

neutropenia is defined as an ANC of ____

<500

94
New cards

neutropenia puts pts at increased risk of _____

infections

95
New cards

what is the formula for ANC?

(% segs + % bands) x WBC

96
New cards

febrile neutropenia definition

have a temp of >/= 101 once or >/= 100.4 sustained

and ANC < 500

97
New cards

febrile neutropenia can lead to alterations in which barriers of the body?

skin, GIT, lungs

98
New cards

most common organisms that cause febrile neutropenia include…

bacteria, fungus, and viruses

99
New cards

what type of bacteria is mostly associated with causing febrile neutropenia

gram negative

100
New cards

which gram negative bacteria is the most likely cause of febrile neutropenia?

pseudomonas